tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Sell
6Bullish
3Neutral
13Bearish
Oscillators
Buy
5Bullish
3Neutral
2Bearish
Moving Averages
Strong Sell
1Bullish
0Neutral
11Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is -0.48, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 22.08, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 22.40, making it a Sell.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Feb 14, 2026, 08:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.90
21.08
20.90
21.08
20.90
21.08
20.90
Fibonacci
21.08
21.08
21.08
21.08
21.08
21.08
21.08

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Feb 14, 2026, 08:24 AM
Period
Simple
Exponential
MA5
21.24Sell
21.25Sell
MA10
21.65Sell
21.62Sell
MA20
22.41Sell
22.08Sell
MA50
22.63Sell
22.40Sell
MA100
22.37Sell
22.15Sell
MA200
21.23Sell
21.12Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 21.62, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 22.15, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 22.63, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 22.37, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 21.23, creating a Sell signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Feb 14, 2026, 08:24 AM
Name
Value
Action
RSI (14)
36.73
Neutral
STOCH (9,6)
7.83
Buy
STOCHRSI (14)
5.38
Buy
MACD (12,26)
-0.48
Buy
ADX (14)
21.23
Neutral
Williams %R
-80.47
Buy
CCI (14)
-118.01
Buy
ATR (14)
0.28
-
Ultimate Oscillator
32.64
Neutral
ROC
-9.70
Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 36.73, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 21.23, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is -118.01, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is -9.70, creating a Sell signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Sell.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 36.73, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is -0.48, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 21.24, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 22.41, which suggests CURE is a Sell.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 22.63, which suggests CURE is a Sell.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 21.23, which suggests CURE is a Sell.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -80.47, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is -118.01, which suggests CURE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement